Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05203172
Title The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements Yes
Sponsors Pfizer
Indications

Advanced Solid Tumor

skin melanoma

colorectal cancer

melanoma

Therapies

Encorafenib

Binimetinib + Encorafenib

Binimetinib + Encorafenib + Ribociclib

Binimetinib + Cetuximab + Encorafenib

Binimetinib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP

Additional content available in CKB BOOST